A Ras/Raf pathway inhibitor, L744,832, induces cytotoxicity and cell death in DLBCL and Burkitt’s lymphoma cells.38 It is possible that RASIP1 plays its lymphoma-promoting role by interacting with Ras. Here, RASIP1 is linked to Burkitt lymphoma.